@article{10902/26635,
year = {2022},
url = {https://hdl.handle.net/10902/26635},
abstract = {We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.},
organization = {Open Access funding enabled and organized by Projekt DEAL.},
publisher = {Nature Publishing Group},
publisher = {Leukemia
. 2022 Jul;36(7):1720-1748},
title = {The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms},
author = {Alaggio, Rita and Amador, Catalina and Anagnostopoulos, Ioannis and Attygalle, Ayoma D and Barreto de Oliveira Araujo, Iguaracyra and Berti, Emilio and Bhagat, Govind and Borges, Anita María and Boyer, Daniel and Calaminici, Mariarita and Chadburn, Amy and Chan, John K C and Cheuk, Wah and Chng, Wee-Joo and Choi, John K and Chuang, Shih-Sung and Coupland, Sarah E and Czader, Magdalena and Dave, Sandeep S and Montes Moreno, Santiago},
}